Gu, Y., Zou, X., Zhu, J., & Wu, G. Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma. BMC.
Chicago Style (17th ed.) CitationGu, Yinfang, Xiaofang Zou, Junlin Zhu, and Guowu Wu. Efficacy and Safety of Camrelizumab Combined with Chemotherapy as Second-line Treatment for Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma. BMC.
MLA (9th ed.) CitationGu, Yinfang, et al. Efficacy and Safety of Camrelizumab Combined with Chemotherapy as Second-line Treatment for Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell Carcinoma. BMC.
Warning: These citations may not always be 100% accurate.